[ Price : $8.95]
FDA warns New Zealands Miers Laboratories about repeat CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
Neurocrine Biosciences reports that its Phase 2 study of NBI-1070770, an investigational NMDA receptor modulator for major depress...[ Price : $8.95]
Alston & Bird attorneys urge medical device companies to move quickly to prepare to implement FDAs new Quality Management System R...[ Price : $8.95]
enGene says Phase 2 data showed that its gene therapy detalimogene voraplasmid produced a 62% complete response rate at six months...[ Price : $8.95]
FDA warns Chinas Taizhou Kangping Medical Science and Technology Co. about CGMP violations in its manufacturing of over-the-counte...[ Price : $8.95]
FDA names 26-year FDA veteran Richard Pazdur as the new CDER director, replacing George Tidmarsh after he recently stepped down am...[ Price : $8.95]
FDA grants Avenzo Therapeutics a fast track designation for AVZO-1418, the companys investigational EGFR/HER3 bispecific antibody-...[ Price : $8.95]
FDA says it will begin removing broad boxed warnings from menopause-related hormone replacement therapy products based on a recent...